Tag: HER2
Living with HER2+ Secondary Breast Cancer: Diane Lavin’s Experience
In our third blog with Make2ndsCount, we’ll be looking in depth at current and future treatments for HER2 secondary breast cancer patients.
HER2 Secondary Breast Cancer: All of the treatments explained
In our third blog with Make2ndsCount, we’ll be looking in depth at current and future treatments for HER2 secondary breast cancer patients.
Enhertu for Secondary Breast Cancer: Science and Stories
Trastuzumab deruxtecan (Enhertu®) is used to treat certain secondary breast cancers. This blog delves into the science while looking at the real experiences of patient’s on this drug.
What is HER2-low Breast Cancer?
HER2-low is a new way to characterise breast cancer. In short, many previously considered HER2-negative breast cancer patients can now be considered HER2-low. This provides a new treatment target for many secondary (metastatic, advanced) breast cancers.
Tumour gene tests: What are they and why should you know about them?
Genomic tests have changed how cancer is treated. In this blog we explain the objective and the different types of genomic tests available.
Untangling monoclonal antibodies – Trastuzumab, Pertuzumab, Atezolizumab
We know that drug names can be confusing. That’s why we’re untangling drug terminology. Starting with the monoclonal antibodies (AKA the mabs).
Clinical Trials for Breast Cancer: Our A to Z Guide
Want to better understand what clinical trials are and what they mean for you? Here is OWise’s extensive guide to all things clinical trials.
It’s All About HER2-Positive Breast Cancer
If you have HER2-positive breast cancer, this is the blog for you! Find out exactly what HER2 is and how it may affect your treatment plan.
HER2 and Herceptin®: A Look at the History
The discovery of the HER2 gene led to the development of Herceptin®: a targeted therapy that is widely used today for HER2+ breast cancer patients.